Search
Displaying 451–460 of 661 for “retinal diseases”
-
- Apr 12, 2026
- 10:00 a.m. (EST)
- 290 Holden Ave, Orlando, FL 32839
VisionWalkVisionWalk is a fun, family-friendly 5K walk that supports the Foundation Fighting Blindness and our mission to find treatments and cures for blinding diseases. Join us for a day of community, celebration, and hope as we take steps toward a brighter future for those living with vision loss.
-
- Apr 11, 2026
- 9:00 a.m. (EST)
- 72nd Street Entrances, New York, NY 10023
VisionWalkVisionWalk is a fun, family-friendly 5K walk that supports the Foundation Fighting Blindness and our mission to find treatments and cures for blinding diseases. Join us for a day of community, celebration, and hope as we take steps toward a brighter future for those living with vision loss.
-
- Apr 5, 2026
- 9:00 a.m. (EST)
- 2800 University Blvd N, Jacksonville, FL 32211
VisionWalkVisionWalk is a fun, family-friendly 5K walk that supports the Foundation Fighting Blindness and our mission to find treatments and cures for blinding diseases. Join us for a day of community, celebration, and hope as we take steps toward a brighter future for those living with vision loss.
-
Foundation Hosts Workshop on USH1B Research and Therapy Development
Research NewsEmerging dual-vector gene therapies to address current cargo-size limitations were highlighted during the meeting.
-
FFB-Funded Scientists Report on Nine Promising Translational Research Efforts
Research NewsThe Foundation Fighting Blindness has taken the translational challenge head on by investing more than $75 million in therapy-development projects with strong clinical-trial potential through its Translational Research Acceleration Program (TRAP), which includes Gund-Harrington Scholar Awards.
-
The Importance of Stem Cells (a guest post from Dr. David Gamm)
Research NewsDr. David Gamm on the potential of stem cell research to benefit patients with retinal degenerations.
-
Watch Mike’s powerful story and see how your donation drives research toward treatments and cures for retinitis pigmentosa and blinding diseases. Donate today.
-
Nacuity’s Antioxidative Therapy NACA Performs Encouragingly in Phase 1/2 Clinical Trial
Research NewsNACA is a gene-agnostic, oral medication designed to preserve vision in people with retinitis pigmentosa and Usher syndrome.
-
Eye on the Cure Podcast | Episode 59: Dr. Robert MacLaren
Eye on the CureDr. Robert MacLaren, a world-renowned retinal surgeon, clinical trial investigator, and research lab leader at the University of Oxford, talks to host Ben Shaberman about the successes and challenges in retinal gene therapy development and clinical trials, as well as advances in robotics for improving retinal surgery outcomes.
-
First Patient Receives AON Therapy for LCA10 in ProQR’s Phase 2/3 Clinical Trial
Research NewsThe treatment, formerly known as QR-110, is designed for people with the retinal disease Leber congenital amaurosis 10
%20(1).png)
